Loading…
Association of chronic heart failure with mortality in old intensive care patients suffering from Covid‐19
Aims Chronic heart failure (CHF) is a major risk factor for mortality in coronavirus disease 2019 (COVID‐19). This prospective international multicentre study investigates the role of pre‐existing CHF on clinical outcomes of critically ill old (≥70 years) intensive care patients with COVID‐19. Metho...
Saved in:
Published in: | ESC Heart Failure 2022-06, Vol.9 (3), p.1756-1765 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c5354-394181a9c4ae461af3b636e2491f5cad219c89fc6ed05979cfd4d422979d7fb3 |
container_end_page | 1765 |
container_issue | 3 |
container_start_page | 1756 |
container_title | ESC Heart Failure |
container_volume | 9 |
creator | Bruno, Raphael Romano Wernly, Bernhard Wolff, Georg Fjølner, Jesper Artigas, Antonio Bollen Pinto, Bernardo Schefold, Joerg C. Kindgen‐Milles, Detlef Baldia, Philipp Heinrich Kelm, Malte Beil, Michael Sviri, Sigal Heerden, Peter Vernon Szczeklik, Wojciech Topeli, Arzu Elhadi, Muhammed Joannidis, Michael Oeyen, Sandra Kondili, Eumorfia Marsh, Brian Andersen, Finn H. Moreno, Rui Leaver, Susannah Boumendil, Ariane De Lange, Dylan W. Guidet, Bertrand Flaatten, Hans Jung, Christian |
description | Aims
Chronic heart failure (CHF) is a major risk factor for mortality in coronavirus disease 2019 (COVID‐19). This prospective international multicentre study investigates the role of pre‐existing CHF on clinical outcomes of critically ill old (≥70 years) intensive care patients with COVID‐19.
Methods and results
Patients with pre‐existing CHF were subclassified as having ischaemic or non‐ischaemic cardiac disease; patients with a documented ejection fraction (EF) were subclassified according to heart failure EF: reduced (HFrEF, n = 132), mild (HFmrEF, n = 91), or preserved (HFpEF, n = 103). Associations of heart failure characteristics with the 30 day mortality were analysed in univariate and multivariate logistic regression analyses. Pre‐existing CHF was reported in 566 of 3917 patients (14%). Patients with CHF were older, frailer, and had significantly higher SOFA scores on admission. CHF patients showed significantly higher crude 30 day mortality [60% vs. 48%, P |
doi_str_mv | 10.1002/ehf2.13854 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_186d2796dc964a2498683610b042eb25</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_186d2796dc964a2498683610b042eb25</doaj_id><sourcerecordid>2638716956</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5354-394181a9c4ae461af3b636e2491f5cad219c89fc6ed05979cfd4d422979d7fb3</originalsourceid><addsrcrecordid>eNp9kstq3DAUhk1oSUKaTR-gCLopgUl1t7UphCE3CHSTvZB1GWuQralkT5hdH6HPmCeJJk5D0kVX5yB9fDpH_FX1GcFzBCH-bjuHzxFpGD2ojjFkbMEajD-86Y-q05zXEELEOGKYHlZHhOGaUgGPq3CRc9RejT4OIDqguxQHr0FnVRqBUz5MyYIHP3agj2lUwY874AsaTCmjHbLfWqBVgTZFYocxgzw5Z5MfVsCl2INl3Hrz-PsPEp-qj06FbE9f6kl1f3V5v7xZ3P28vl1e3C00I4wuiKCoQUpoqizlSDnScsItpgI5ppXBSOhGOM2tgUzUQjtDDcW4tKZ2LTmpbmetiWotN8n3Ku1kVF4-H8S0kmU5r4OVqOEG14IbLThV5YWGN4Qj2EKKbYtZcf2YXZup7a3RZcGkwjvp-5vBd3IVt1JAzpp6L_j2Ikjx12TzKHuftQ1BDTZOWWJOmhpxwXhBv_6DruOUhvJThWICQsIgKdTZTOkUc07WvQ6DoNxHQu4jIZ8jUeAvb8d_Rf8GoABoBh58sLv_qOTlzRWepU9u98FS</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2659003503</pqid></control><display><type>article</type><title>Association of chronic heart failure with mortality in old intensive care patients suffering from Covid‐19</title><source>Open Access: Wiley-Blackwell Open Access Journals</source><source>Publicly Available Content Database</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Bruno, Raphael Romano ; Wernly, Bernhard ; Wolff, Georg ; Fjølner, Jesper ; Artigas, Antonio ; Bollen Pinto, Bernardo ; Schefold, Joerg C. ; Kindgen‐Milles, Detlef ; Baldia, Philipp Heinrich ; Kelm, Malte ; Beil, Michael ; Sviri, Sigal ; Heerden, Peter Vernon ; Szczeklik, Wojciech ; Topeli, Arzu ; Elhadi, Muhammed ; Joannidis, Michael ; Oeyen, Sandra ; Kondili, Eumorfia ; Marsh, Brian ; Andersen, Finn H. ; Moreno, Rui ; Leaver, Susannah ; Boumendil, Ariane ; De Lange, Dylan W. ; Guidet, Bertrand ; Flaatten, Hans ; Jung, Christian</creator><creatorcontrib>Bruno, Raphael Romano ; Wernly, Bernhard ; Wolff, Georg ; Fjølner, Jesper ; Artigas, Antonio ; Bollen Pinto, Bernardo ; Schefold, Joerg C. ; Kindgen‐Milles, Detlef ; Baldia, Philipp Heinrich ; Kelm, Malte ; Beil, Michael ; Sviri, Sigal ; Heerden, Peter Vernon ; Szczeklik, Wojciech ; Topeli, Arzu ; Elhadi, Muhammed ; Joannidis, Michael ; Oeyen, Sandra ; Kondili, Eumorfia ; Marsh, Brian ; Andersen, Finn H. ; Moreno, Rui ; Leaver, Susannah ; Boumendil, Ariane ; De Lange, Dylan W. ; Guidet, Bertrand ; Flaatten, Hans ; Jung, Christian ; COVIP study group</creatorcontrib><description>Aims
Chronic heart failure (CHF) is a major risk factor for mortality in coronavirus disease 2019 (COVID‐19). This prospective international multicentre study investigates the role of pre‐existing CHF on clinical outcomes of critically ill old (≥70 years) intensive care patients with COVID‐19.
Methods and results
Patients with pre‐existing CHF were subclassified as having ischaemic or non‐ischaemic cardiac disease; patients with a documented ejection fraction (EF) were subclassified according to heart failure EF: reduced (HFrEF, n = 132), mild (HFmrEF, n = 91), or preserved (HFpEF, n = 103). Associations of heart failure characteristics with the 30 day mortality were analysed in univariate and multivariate logistic regression analyses. Pre‐existing CHF was reported in 566 of 3917 patients (14%). Patients with CHF were older, frailer, and had significantly higher SOFA scores on admission. CHF patients showed significantly higher crude 30 day mortality [60% vs. 48%, P < 0.001; odds ratio 1.87, 95% confidence interval (CI) 1.5–2.3] and 3 month mortality (69% vs. 56%, P < 0.001). After multivariate adjustment for confounders (SOFA, age, sex, and frailty), no independent association of CHF with mortality remained [adjusted odds ratio (aOR) 1.2, 95% CI 0.5–1.5; P = 0.137]. More patients suffered from pre‐existing ischaemic than from non‐ischaemic disease [233 vs. 328 patients (n = 5 unknown aetiology)]. There were no differences in baseline characteristics between ischaemic and non‐ischaemic disease or between HFrEF, HFmrEF, and HFpEF. Crude 30 day mortality was significantly higher in HFrEF compared with HFpEF (64% vs. 48%, P = 0.042). EF as a continuous variable was not independently associated with 30 day mortality (aOR 0.98, 95% CI 0.9–1.0; P = 0.128).
Conclusions
In critically ill older COVID‐19 patients, pre‐existing CHF was not independently associated with 30 day mortality.
Trial registration number: NCT04321265.</description><identifier>ISSN: 2055-5822</identifier><identifier>EISSN: 2055-5822</identifier><identifier>DOI: 10.1002/ehf2.13854</identifier><identifier>PMID: 35274490</identifier><language>eng</language><publisher>England: John Wiley & Sons, Inc</publisher><subject>Cardiovascular disease ; Chronic Disease ; Coronaviruses ; COVID-19 ; COVID-19 - complications ; COVID-19 - epidemiology ; Critical Care ; Critical Illness ; Elderly ; Heart failure ; Heart Failure - complications ; Heart Failure - epidemiology ; Hospitalization ; Humans ; Mortality ; Original ; Prognosis ; Prospective Studies ; Stroke Volume</subject><ispartof>ESC Heart Failure, 2022-06, Vol.9 (3), p.1756-1765</ispartof><rights>2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.</rights><rights>2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c5354-394181a9c4ae461af3b636e2491f5cad219c89fc6ed05979cfd4d422979d7fb3</cites><orcidid>0000-0003-3776-3530 ; 0000-0001-8325-250X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2659003503/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2659003503?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,11542,25732,27903,27904,36991,36992,38495,43874,44569,46030,46454,53769,53771,74158,74872</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35274490$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bruno, Raphael Romano</creatorcontrib><creatorcontrib>Wernly, Bernhard</creatorcontrib><creatorcontrib>Wolff, Georg</creatorcontrib><creatorcontrib>Fjølner, Jesper</creatorcontrib><creatorcontrib>Artigas, Antonio</creatorcontrib><creatorcontrib>Bollen Pinto, Bernardo</creatorcontrib><creatorcontrib>Schefold, Joerg C.</creatorcontrib><creatorcontrib>Kindgen‐Milles, Detlef</creatorcontrib><creatorcontrib>Baldia, Philipp Heinrich</creatorcontrib><creatorcontrib>Kelm, Malte</creatorcontrib><creatorcontrib>Beil, Michael</creatorcontrib><creatorcontrib>Sviri, Sigal</creatorcontrib><creatorcontrib>Heerden, Peter Vernon</creatorcontrib><creatorcontrib>Szczeklik, Wojciech</creatorcontrib><creatorcontrib>Topeli, Arzu</creatorcontrib><creatorcontrib>Elhadi, Muhammed</creatorcontrib><creatorcontrib>Joannidis, Michael</creatorcontrib><creatorcontrib>Oeyen, Sandra</creatorcontrib><creatorcontrib>Kondili, Eumorfia</creatorcontrib><creatorcontrib>Marsh, Brian</creatorcontrib><creatorcontrib>Andersen, Finn H.</creatorcontrib><creatorcontrib>Moreno, Rui</creatorcontrib><creatorcontrib>Leaver, Susannah</creatorcontrib><creatorcontrib>Boumendil, Ariane</creatorcontrib><creatorcontrib>De Lange, Dylan W.</creatorcontrib><creatorcontrib>Guidet, Bertrand</creatorcontrib><creatorcontrib>Flaatten, Hans</creatorcontrib><creatorcontrib>Jung, Christian</creatorcontrib><creatorcontrib>COVIP study group</creatorcontrib><title>Association of chronic heart failure with mortality in old intensive care patients suffering from Covid‐19</title><title>ESC Heart Failure</title><addtitle>ESC Heart Fail</addtitle><description>Aims
Chronic heart failure (CHF) is a major risk factor for mortality in coronavirus disease 2019 (COVID‐19). This prospective international multicentre study investigates the role of pre‐existing CHF on clinical outcomes of critically ill old (≥70 years) intensive care patients with COVID‐19.
Methods and results
Patients with pre‐existing CHF were subclassified as having ischaemic or non‐ischaemic cardiac disease; patients with a documented ejection fraction (EF) were subclassified according to heart failure EF: reduced (HFrEF, n = 132), mild (HFmrEF, n = 91), or preserved (HFpEF, n = 103). Associations of heart failure characteristics with the 30 day mortality were analysed in univariate and multivariate logistic regression analyses. Pre‐existing CHF was reported in 566 of 3917 patients (14%). Patients with CHF were older, frailer, and had significantly higher SOFA scores on admission. CHF patients showed significantly higher crude 30 day mortality [60% vs. 48%, P < 0.001; odds ratio 1.87, 95% confidence interval (CI) 1.5–2.3] and 3 month mortality (69% vs. 56%, P < 0.001). After multivariate adjustment for confounders (SOFA, age, sex, and frailty), no independent association of CHF with mortality remained [adjusted odds ratio (aOR) 1.2, 95% CI 0.5–1.5; P = 0.137]. More patients suffered from pre‐existing ischaemic than from non‐ischaemic disease [233 vs. 328 patients (n = 5 unknown aetiology)]. There were no differences in baseline characteristics between ischaemic and non‐ischaemic disease or between HFrEF, HFmrEF, and HFpEF. Crude 30 day mortality was significantly higher in HFrEF compared with HFpEF (64% vs. 48%, P = 0.042). EF as a continuous variable was not independently associated with 30 day mortality (aOR 0.98, 95% CI 0.9–1.0; P = 0.128).
Conclusions
In critically ill older COVID‐19 patients, pre‐existing CHF was not independently associated with 30 day mortality.
Trial registration number: NCT04321265.</description><subject>Cardiovascular disease</subject><subject>Chronic Disease</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - complications</subject><subject>COVID-19 - epidemiology</subject><subject>Critical Care</subject><subject>Critical Illness</subject><subject>Elderly</subject><subject>Heart failure</subject><subject>Heart Failure - complications</subject><subject>Heart Failure - epidemiology</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Mortality</subject><subject>Original</subject><subject>Prognosis</subject><subject>Prospective Studies</subject><subject>Stroke Volume</subject><issn>2055-5822</issn><issn>2055-5822</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kstq3DAUhk1oSUKaTR-gCLopgUl1t7UphCE3CHSTvZB1GWuQralkT5hdH6HPmCeJJk5D0kVX5yB9fDpH_FX1GcFzBCH-bjuHzxFpGD2ojjFkbMEajD-86Y-q05zXEELEOGKYHlZHhOGaUgGPq3CRc9RejT4OIDqguxQHr0FnVRqBUz5MyYIHP3agj2lUwY874AsaTCmjHbLfWqBVgTZFYocxgzw5Z5MfVsCl2INl3Hrz-PsPEp-qj06FbE9f6kl1f3V5v7xZ3P28vl1e3C00I4wuiKCoQUpoqizlSDnScsItpgI5ppXBSOhGOM2tgUzUQjtDDcW4tKZ2LTmpbmetiWotN8n3Ku1kVF4-H8S0kmU5r4OVqOEG14IbLThV5YWGN4Qj2EKKbYtZcf2YXZup7a3RZcGkwjvp-5vBd3IVt1JAzpp6L_j2Ikjx12TzKHuftQ1BDTZOWWJOmhpxwXhBv_6DruOUhvJThWICQsIgKdTZTOkUc07WvQ6DoNxHQu4jIZ8jUeAvb8d_Rf8GoABoBh58sLv_qOTlzRWepU9u98FS</recordid><startdate>202206</startdate><enddate>202206</enddate><creator>Bruno, Raphael Romano</creator><creator>Wernly, Bernhard</creator><creator>Wolff, Georg</creator><creator>Fjølner, Jesper</creator><creator>Artigas, Antonio</creator><creator>Bollen Pinto, Bernardo</creator><creator>Schefold, Joerg C.</creator><creator>Kindgen‐Milles, Detlef</creator><creator>Baldia, Philipp Heinrich</creator><creator>Kelm, Malte</creator><creator>Beil, Michael</creator><creator>Sviri, Sigal</creator><creator>Heerden, Peter Vernon</creator><creator>Szczeklik, Wojciech</creator><creator>Topeli, Arzu</creator><creator>Elhadi, Muhammed</creator><creator>Joannidis, Michael</creator><creator>Oeyen, Sandra</creator><creator>Kondili, Eumorfia</creator><creator>Marsh, Brian</creator><creator>Andersen, Finn H.</creator><creator>Moreno, Rui</creator><creator>Leaver, Susannah</creator><creator>Boumendil, Ariane</creator><creator>De Lange, Dylan W.</creator><creator>Guidet, Bertrand</creator><creator>Flaatten, Hans</creator><creator>Jung, Christian</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-3776-3530</orcidid><orcidid>https://orcid.org/0000-0001-8325-250X</orcidid></search><sort><creationdate>202206</creationdate><title>Association of chronic heart failure with mortality in old intensive care patients suffering from Covid‐19</title><author>Bruno, Raphael Romano ; Wernly, Bernhard ; Wolff, Georg ; Fjølner, Jesper ; Artigas, Antonio ; Bollen Pinto, Bernardo ; Schefold, Joerg C. ; Kindgen‐Milles, Detlef ; Baldia, Philipp Heinrich ; Kelm, Malte ; Beil, Michael ; Sviri, Sigal ; Heerden, Peter Vernon ; Szczeklik, Wojciech ; Topeli, Arzu ; Elhadi, Muhammed ; Joannidis, Michael ; Oeyen, Sandra ; Kondili, Eumorfia ; Marsh, Brian ; Andersen, Finn H. ; Moreno, Rui ; Leaver, Susannah ; Boumendil, Ariane ; De Lange, Dylan W. ; Guidet, Bertrand ; Flaatten, Hans ; Jung, Christian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5354-394181a9c4ae461af3b636e2491f5cad219c89fc6ed05979cfd4d422979d7fb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Cardiovascular disease</topic><topic>Chronic Disease</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - complications</topic><topic>COVID-19 - epidemiology</topic><topic>Critical Care</topic><topic>Critical Illness</topic><topic>Elderly</topic><topic>Heart failure</topic><topic>Heart Failure - complications</topic><topic>Heart Failure - epidemiology</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Mortality</topic><topic>Original</topic><topic>Prognosis</topic><topic>Prospective Studies</topic><topic>Stroke Volume</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bruno, Raphael Romano</creatorcontrib><creatorcontrib>Wernly, Bernhard</creatorcontrib><creatorcontrib>Wolff, Georg</creatorcontrib><creatorcontrib>Fjølner, Jesper</creatorcontrib><creatorcontrib>Artigas, Antonio</creatorcontrib><creatorcontrib>Bollen Pinto, Bernardo</creatorcontrib><creatorcontrib>Schefold, Joerg C.</creatorcontrib><creatorcontrib>Kindgen‐Milles, Detlef</creatorcontrib><creatorcontrib>Baldia, Philipp Heinrich</creatorcontrib><creatorcontrib>Kelm, Malte</creatorcontrib><creatorcontrib>Beil, Michael</creatorcontrib><creatorcontrib>Sviri, Sigal</creatorcontrib><creatorcontrib>Heerden, Peter Vernon</creatorcontrib><creatorcontrib>Szczeklik, Wojciech</creatorcontrib><creatorcontrib>Topeli, Arzu</creatorcontrib><creatorcontrib>Elhadi, Muhammed</creatorcontrib><creatorcontrib>Joannidis, Michael</creatorcontrib><creatorcontrib>Oeyen, Sandra</creatorcontrib><creatorcontrib>Kondili, Eumorfia</creatorcontrib><creatorcontrib>Marsh, Brian</creatorcontrib><creatorcontrib>Andersen, Finn H.</creatorcontrib><creatorcontrib>Moreno, Rui</creatorcontrib><creatorcontrib>Leaver, Susannah</creatorcontrib><creatorcontrib>Boumendil, Ariane</creatorcontrib><creatorcontrib>De Lange, Dylan W.</creatorcontrib><creatorcontrib>Guidet, Bertrand</creatorcontrib><creatorcontrib>Flaatten, Hans</creatorcontrib><creatorcontrib>Jung, Christian</creatorcontrib><creatorcontrib>COVIP study group</creatorcontrib><collection>Open Access: Wiley-Blackwell Open Access Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>ESC Heart Failure</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bruno, Raphael Romano</au><au>Wernly, Bernhard</au><au>Wolff, Georg</au><au>Fjølner, Jesper</au><au>Artigas, Antonio</au><au>Bollen Pinto, Bernardo</au><au>Schefold, Joerg C.</au><au>Kindgen‐Milles, Detlef</au><au>Baldia, Philipp Heinrich</au><au>Kelm, Malte</au><au>Beil, Michael</au><au>Sviri, Sigal</au><au>Heerden, Peter Vernon</au><au>Szczeklik, Wojciech</au><au>Topeli, Arzu</au><au>Elhadi, Muhammed</au><au>Joannidis, Michael</au><au>Oeyen, Sandra</au><au>Kondili, Eumorfia</au><au>Marsh, Brian</au><au>Andersen, Finn H.</au><au>Moreno, Rui</au><au>Leaver, Susannah</au><au>Boumendil, Ariane</au><au>De Lange, Dylan W.</au><au>Guidet, Bertrand</au><au>Flaatten, Hans</au><au>Jung, Christian</au><aucorp>COVIP study group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association of chronic heart failure with mortality in old intensive care patients suffering from Covid‐19</atitle><jtitle>ESC Heart Failure</jtitle><addtitle>ESC Heart Fail</addtitle><date>2022-06</date><risdate>2022</risdate><volume>9</volume><issue>3</issue><spage>1756</spage><epage>1765</epage><pages>1756-1765</pages><issn>2055-5822</issn><eissn>2055-5822</eissn><abstract>Aims
Chronic heart failure (CHF) is a major risk factor for mortality in coronavirus disease 2019 (COVID‐19). This prospective international multicentre study investigates the role of pre‐existing CHF on clinical outcomes of critically ill old (≥70 years) intensive care patients with COVID‐19.
Methods and results
Patients with pre‐existing CHF were subclassified as having ischaemic or non‐ischaemic cardiac disease; patients with a documented ejection fraction (EF) were subclassified according to heart failure EF: reduced (HFrEF, n = 132), mild (HFmrEF, n = 91), or preserved (HFpEF, n = 103). Associations of heart failure characteristics with the 30 day mortality were analysed in univariate and multivariate logistic regression analyses. Pre‐existing CHF was reported in 566 of 3917 patients (14%). Patients with CHF were older, frailer, and had significantly higher SOFA scores on admission. CHF patients showed significantly higher crude 30 day mortality [60% vs. 48%, P < 0.001; odds ratio 1.87, 95% confidence interval (CI) 1.5–2.3] and 3 month mortality (69% vs. 56%, P < 0.001). After multivariate adjustment for confounders (SOFA, age, sex, and frailty), no independent association of CHF with mortality remained [adjusted odds ratio (aOR) 1.2, 95% CI 0.5–1.5; P = 0.137]. More patients suffered from pre‐existing ischaemic than from non‐ischaemic disease [233 vs. 328 patients (n = 5 unknown aetiology)]. There were no differences in baseline characteristics between ischaemic and non‐ischaemic disease or between HFrEF, HFmrEF, and HFpEF. Crude 30 day mortality was significantly higher in HFrEF compared with HFpEF (64% vs. 48%, P = 0.042). EF as a continuous variable was not independently associated with 30 day mortality (aOR 0.98, 95% CI 0.9–1.0; P = 0.128).
Conclusions
In critically ill older COVID‐19 patients, pre‐existing CHF was not independently associated with 30 day mortality.
Trial registration number: NCT04321265.</abstract><cop>England</cop><pub>John Wiley & Sons, Inc</pub><pmid>35274490</pmid><doi>10.1002/ehf2.13854</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-3776-3530</orcidid><orcidid>https://orcid.org/0000-0001-8325-250X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2055-5822 |
ispartof | ESC Heart Failure, 2022-06, Vol.9 (3), p.1756-1765 |
issn | 2055-5822 2055-5822 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_186d2796dc964a2498683610b042eb25 |
source | Open Access: Wiley-Blackwell Open Access Journals; Publicly Available Content Database; PubMed Central; Coronavirus Research Database |
subjects | Cardiovascular disease Chronic Disease Coronaviruses COVID-19 COVID-19 - complications COVID-19 - epidemiology Critical Care Critical Illness Elderly Heart failure Heart Failure - complications Heart Failure - epidemiology Hospitalization Humans Mortality Original Prognosis Prospective Studies Stroke Volume |
title | Association of chronic heart failure with mortality in old intensive care patients suffering from Covid‐19 |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T07%3A01%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20of%20chronic%20heart%20failure%20with%20mortality%20in%20old%20intensive%20care%20patients%20suffering%20from%20Covid%E2%80%9019&rft.jtitle=ESC%20Heart%20Failure&rft.au=Bruno,%20Raphael%20Romano&rft.aucorp=COVIP%20study%20group&rft.date=2022-06&rft.volume=9&rft.issue=3&rft.spage=1756&rft.epage=1765&rft.pages=1756-1765&rft.issn=2055-5822&rft.eissn=2055-5822&rft_id=info:doi/10.1002/ehf2.13854&rft_dat=%3Cproquest_doaj_%3E2638716956%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5354-394181a9c4ae461af3b636e2491f5cad219c89fc6ed05979cfd4d422979d7fb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2659003503&rft_id=info:pmid/35274490&rfr_iscdi=true |